Fragmented QRS and myocardial performance index in nephrotic syndrome
نویسندگان
چکیده
منابع مشابه
Fragmented QRS and myocardial performance index in nephrotic syndrome
The recent report on “Fragmented QRS and myocardial performance index in nephrotic syndrome” published is very interesting (1). Özkan et al. (1) concluded that the “determination of fQRS in patients with nephrotic syndrome (NS) in surface ECG, an easily accessible technique, can be used as a parameter in the prediction of myocardial functions.” In fact, it is already known that “fQRS may be use...
متن کاملDiffuse Fragmented QRS as an Index of Extensive Myocardial Scar
A 70-year-old man with history of previous myocardial infarction was referred for cardiac resynchronization therapy (CRT) implantation. Echocardiography showed global wall motion abnormality and non-viable myocardium with ejection fraction of 15% and large apical aneurysm. Electrocardiography (ECG) revealed sinus rhythm with wide QRS (200 ms). Of note is the finding of marked fragmentation of Q...
متن کاملFragmented QRS frequency in patients with cardiac syndrome X
The term “cardiac syndrome X” (CSX) was introduced more than 40 year ago by Kemp (1) who described a group of patients with angina-like chest pains and normal coronary artery angiograms. Since then, the mosaic of knowledge has gradually built up; however, the letter “X” in this term characterizes the fact that evidence and knowledge on this syndrome are still limited and controversial (2). CSX ...
متن کاملFragmented QRS frequency in patients with cardiac syndrome X
OBJECTIVE Cardiac syndrome X (CSX) is characterised by typical exertional chest pain, a positive response to exercise testing, and a normal coronary angiography. The relationship of CSX with myocardial fibrosis and ischemia has been clearly demonstrated in previous studies. In addition, fragmented QRS (fQRS) has been reported in the literature as an indicator of myocardial fibrosis. The aim of ...
متن کاملFragmented QRS and Chagas' disease
Unfortunately, the authors have missed our 2 publications on this topic which have been tested in a larger population of CD patients with an implantable cardioverter-defibrillator (ICD) (FECHA study) [2,3]. We included 98 patients from 14 centers in Latin America, all of them with CD cardiomyopathy and an implantable cardioverter-defibrillator (ICD). The mean follow-up was 33±20 months. Mean LV...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Anadolu Kardiyoloji Dergisi/The Anatolian Journal of Cardiology
سال: 2015
ISSN: 1302-8723,1308-0032
DOI: 10.5152/akd.2015.5878